Study Details
Testing the Drug Cenobamate for People with Newly Diagnosed or Recurrent Partial-Onset Epilepsy
(IRB#: IRB_00185320)
Partial-onset epilepsy is a type of seizure that starts in a specific area of the brain. It can cause various symptoms, such as unusual movements, changes in senses, or even loss of awareness. Cenobamate is an approved drug to treat people with partial onset-seizures. This study wants to see how effective and safe the drug is to help people recently diagnosed or have experienced a recurring partial-onset seizure. People in the study will take specific doses of Cenobamate over time. Being in the study requires attending in person study visits at the clinic. Participation may last up to 2 years with about 14 study visits. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 to 74 years old
- Diagnosis of partial-onset seizures
- Newly diagnosed or have recurrent epilepsy with specific criteria
- Childbearing age must use specific birth control
- Able to attend in person visits at the study clinic
Exclusion Criteria
- Have only simple partial-onset seizures (focal aware seizures) without motor signs
- Have seizure clusters where individual seizures cannot be counted
- Current or history of Lennox-Gastaut syndrome
- Dementia
- Pregnant or breastfeeding
Will I be paid for my time?
Yes
IRB#: IRB_00185320
PI: Amir Arain
Department: NEUROLOGY
Approval Date: 2025-06-18 06:00:00
Study Categories: Brain Health Studies
Specialties: Neurology
I am Interested